{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T12:43:54Z","timestamp":1790858634866,"version":"4.1.0"},"reference-count":290,"publisher":"Aging Biology LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AgingBio"],"DOI":"10.59368\/agingbio.20230010","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T15:48:34Z","timestamp":1691164114000},"page":"20230010","source":"Crossref","is-referenced-by-count":9,"title":["Aging, Parkinson\u2019s Disease, and Models: What Are the Challenges?"],"prefix":"10.59368","volume":"1","author":[{"given":"Ilaria","family":"Bellantuono","sequence":"first","affiliation":[{"name":"The Healthy Lifespan Institute","place":[", Sheffield, United Kingdom"]},{"name":"Department of Oncology and Metabolism, The Medical School","place":[", Sheffield, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Mortiboys","sequence":"first","affiliation":[{"name":"The Healthy Lifespan Institute","place":[", Sheffield, United Kingdom"]},{"name":"Department of Neuroscience, Sheffield Institute of Translational Neuroscience (SITraN), University of Sheffield","place":[", Sheffield, United Kindgom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Rocha","sequence":"additional","affiliation":[{"name":"Pittsburgh Institute for Neurodegenerative Diseases and Department of Neurology, University of Pittsburgh School of Medicine, University of Pittsburgh","place":["Pittsburgh, PA, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Chamoli","sequence":"additional","affiliation":[{"name":"Buck Institute for Research on Aging","place":["Novato, CA, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shankar J.","family":"Chinta","sequence":"additional","affiliation":[{"name":"Buck Institute for Research on Aging","place":["Novato, CA, USA"]},{"name":"Touro University California, College of Pharmacy","place":["Vallejo, CA, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie K.","family":"Andersen","sequence":"additional","affiliation":[{"name":"Buck Institute for Research on Aging","place":["Novato, CA, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby","family":"Wallis","sequence":"additional","affiliation":[{"name":"The Healthy Lifespan Institute","place":[", Sheffield, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"Bezard","sequence":"additional","affiliation":[{"name":"University of Bordeaux","place":[", Bordeaux, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Goldberg","sequence":"additional","affiliation":[{"name":"The University of Alabama","place":["Birmingham, AL, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Greenamyre","sequence":"additional","affiliation":[{"name":"Pittsburgh Institute for Neurodegenerative Diseases and Department of Neurology, University of Pittsburgh School of Medicine, University of Pittsburgh","place":["Pittsburgh, PA, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren","family":"Hirst","sequence":"additional","affiliation":[{"name":"Biogen","place":["Cambridge, MA, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"We-Li","family":"Kuan","sequence":"additional","affiliation":[{"name":"Department of Clinical Neurosciences, University of Cambridge","place":["Cambridge, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deniz","family":"Kirik","sequence":"additional","affiliation":[{"name":"Brain Repair and Imaging in Neural Systems (BRAINS)","place":["Lund, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Niedernhofer","sequence":"additional","affiliation":[{"name":"Institute on the Biology of Aging and Metabolism, University of Minnesota","place":["Minneapolis, MN, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irit","family":"Rappley","sequence":"additional","affiliation":[{"name":"Recursion pharmaceuticals","place":["Salt Lake City, UT, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Padmanabhan","sequence":"additional","affiliation":[{"name":"The Michael J. Fox Foundation for Parkinson\u2019s Disease","place":["New York, NY, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis-Eric","family":"Trudeau","sequence":"additional","affiliation":[{"name":"Department of pharmacology and physiology, Faculty of Medicine, Universit\u00e9 de Montr\u00e9al","place":["Montreal, QC, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Spillantini","sequence":"additional","affiliation":[{"name":"Clinical Neurosciences, University of Cambridge","place":["Cambridge, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Scott","sequence":"additional","affiliation":[{"name":"Cure Parkinson\u2019s","place":["London, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz","family":"Studer","sequence":"additional","affiliation":[{"name":"The Center for Stem Cell Biology and Developmental Biology Program, Sloan-Kettering Institute for Cancer Research","place":[", New York, NY, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"38491","published-online":{"date-parts":[[2023,8,4]]},"reference":[{"issue":"10291","key":"10.59368\/agingbio.20230010_r1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","unstructured":"PMID: 33848468","journal-title":"Lancet"},{"issue":"1","key":"10.59368\/agingbio.20230010_r2","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41531-018-0073-1","article-title":"Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder","volume":"5","author":"Chahine","year":"2019","unstructured":"PMID: 30701189","journal-title":"NPJ Park. Dis."},{"issue":"8","key":"10.59368\/agingbio.20230010_r3","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1093\/brain\/awaa181","article-title":"Natural history of motor symptoms in Parkinson\u2019s disease and the long-duration response to levodopa","volume":"143","author":"Cilia","year":"2020","unstructured":"PMID: 32844196","journal-title":"Brain"},{"issue":"1","key":"10.59368\/agingbio.20230010_r4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-54029-w","article-title":"Parkinson\u2019s disease prognostic scores for progression of cognitive decline","volume":"9","author":"Gramotnev","year":"2019","unstructured":"PMID: 31767922","journal-title":"Sci. Rep."},{"issue":"2","key":"10.59368\/agingbio.20230010_r5","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/mds.28349","article-title":"Disease progression in patients with Parkin-related Parkinson\u2019s disease in a longitudinal cohort","volume":"36","author":"Sun","year":"2021","unstructured":"PMID: 33107659","journal-title":"Mov. Disord."},{"key":"10.59368\/agingbio.20230010_r6","doi-asserted-by":"publisher","first-page":"S31","DOI":"10.3233\/JPD-181477","article-title":"The gut and Parkinson\u2019s disease: Hype or hope?","volume":"8","author":"Scheperjans","year":"2018","unstructured":"PMID: 30584161","journal-title":"J. Parkinsons. Dis."},{"issue":"2","key":"10.59368\/agingbio.20230010_r7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","unstructured":"PMID: 12498954","journal-title":"Neurobiol. Aging"},{"issue":"6","key":"10.59368\/agingbio.20230010_r8","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1093\/brain\/awab061","article-title":"Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats","volume":"144","author":"Van Den Berge","year":"2021","unstructured":"PMID: 33880502","journal-title":"Brain"},{"key":"10.59368\/agingbio.20230010_r9","first-page":"24","article-title":"Neuromelanin MR imaging in Parkinson\u2019s disease","volume":"2","author":"Reim\u00e3o","year":"2016","journal-title":"Oru. \u2013 CNS J."},{"issue":"13","key":"10.59368\/agingbio.20230010_r10","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1002\/mds.25945","article-title":"The prevalence of Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"29","author":"Pringsheim","year":"2014","unstructured":"PMID: 24976103","journal-title":"Mov. Disord."},{"issue":"5","key":"10.59368\/agingbio.20230010_r11","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1046\/j.1365-2990.1999.00202.x","article-title":"Unbiased morphometrical measurements show loss of pigmented nigral neurones with ageing","volume":"25","author":"Ma","year":"1999","unstructured":"PMID: 10564529","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"2","key":"10.59368\/agingbio.20230010_r12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/ana.22588","article-title":"Nigral pathology and Parkinsonian signs in elders without Parkinson disease","volume":"71","author":"Buchman","year":"2012","unstructured":"PMID: 22367997","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.59368\/agingbio.20230010_r13","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1002\/cne.21333","article-title":"Age-related accumulation of Marinesco bodies and lipofuscin in rhesus monkey midbrain dopamine neurons: Relevance to selective neuronal vulnerability","volume":"502","author":"Kanaan","year":"2007","unstructured":"PMID: 17436290","journal-title":"J. Comp. Neurol."},{"issue":"6","key":"10.59368\/agingbio.20230010_r14","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The Hallmarks of Aging Europe PMC Funders Group","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","unstructured":"PMID: 23746838","journal-title":"Cell"},{"issue":"2","key":"10.59368\/agingbio.20230010_r15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","article-title":"Hallmarks of aging: An expanding universe","volume":"186","author":"L\u00f3pez-Ot\u00edn","year":"2023","unstructured":"PMID: 36599349","journal-title":"Cell"},{"issue":"6","key":"10.59368\/agingbio.20230010_r16","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1111\/j.1471-4159.1990.tb05809.x","article-title":"Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson\u2019s disease","volume":"55","author":"Schapira","year":"1990","unstructured":"PMID: 2121905","journal-title":"J. Neurochem."},{"issue":"6","key":"10.59368\/agingbio.20230010_r17","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1289\/ehp.1002839","article-title":"Rotenone, paraquat, and Parkinson\u2019s disease","volume":"119","author":"Tanner","year":"2011","unstructured":"PMID: 21269927","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.59368\/agingbio.20230010_r18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-020-00367-7","article-title":"PINK1 and Parkin mitochondrial quality control: A source of regional vulnerability in Parkinson\u2019s disease","volume":"15","author":"Ge","year":"2020","unstructured":"PMID: 32169097","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.59368\/agingbio.20230010_r19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/ana.21492","article-title":"Mitochondrial function and morphology are impaired in Parkin-mutant fibroblasts","volume":"64","author":"Mortiboys","year":"2008","unstructured":"PMID: 19067348","journal-title":"Ann. Neurol."},{"issue":"22","key":"10.59368\/agingbio.20230010_r20","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1212\/WNL.0b013e3181ff9685","article-title":"Mitochondrial impairment in patients with Parkinson disease with the G2019S mutation in LRRK2","volume":"75","author":"Mortiboys","year":"2010","unstructured":"PMID: 21115957","journal-title":"Neurology"},{"issue":"10","key":"10.59368\/agingbio.20230010_r21","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1212\/WNL.0000000000001905","article-title":"UDCA exerts beneficial effect on mitochondrial dysfunction in LRRK2(G2019S) carriers and in vivo","volume":"85","author":"Mortiboys","year":"2015","unstructured":"PMID: 26253449","journal-title":"Neurology"},{"key":"10.59368\/agingbio.20230010_r22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.nbd.2017.04.004","article-title":"Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson\u2019s disease","volume":"109","author":"Rocha","year":"2018","unstructured":"PMID: 28400134","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.59368\/agingbio.20230010_r23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-72345-4","article-title":"Oxidative switch drives mitophagy defects in dopaminergic Parkin mutant patient neurons","volume":"10","author":"Schwartzentruber","year":"2020","unstructured":"PMID: 32968089","journal-title":"Sci. Rep."},{"issue":"9","key":"10.59368\/agingbio.20230010_r24","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1093\/hmg\/dds003","article-title":"LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1","volume":"21","author":"Wang","year":"2012","unstructured":"PMID: 22228096","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"10.59368\/agingbio.20230010_r25","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1016\/j.jmb.2020.01.037","article-title":"Autophagy in Parkinson\u2019s disease","volume":"432","author":"Hou","year":"2020","unstructured":"PMID: 32061929","journal-title":"J. Mol. Biol."},{"issue":"6 Suppl 3","key":"10.59368\/agingbio.20230010_r26","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.1212\/wnl.47.6_suppl_3.161s","article-title":"Oxidative stress and the pathogenesis of Parkinson\u2019s disease","volume":"47","author":"Jenner","year":"1996","unstructured":"PMID: 8959985","journal-title":"Neurology."},{"issue":"5","key":"10.59368\/agingbio.20230010_r27","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S0002-9440(10)65396-5","article-title":"Parkinson\u2019s disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons","volume":"154","author":"Zhang","year":"1999","unstructured":"PMID: 10329595","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.59368\/agingbio.20230010_r28","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.tibs.2016.01.005","article-title":"Mitochondrial dysfunction meets senescence","volume":"41","author":"Gallage","year":"2016","unstructured":"PMID: 26874922","journal-title":"Trends Biochem. Sci."},{"issue":"4","key":"10.59368\/agingbio.20230010_r29","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.celrep.2017.12.092","article-title":"Cellular senescence is induced by the environmental neurotoxin paraquat and contributes to neuropathology linked to Parkinson\u2019s disease","volume":"22","author":"Chinta","year":"2018","unstructured":"PMID: 29386135","journal-title":"Cell Rep."},{"key":"10.59368\/agingbio.20230010_r30","doi-asserted-by":"publisher","DOI":"10.1038\/npjparkd.2015.22","article-title":"Delaying aging is neuroprotective in Parkinson\u2019s disease: A genetic analysis in C. Elegans models","volume":"1","author":"Cooper","year":"2015","unstructured":"PMID: 28725688","journal-title":"Parkinsons. Dis."},{"issue":"12","key":"10.59368\/agingbio.20230010_r31","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/embor.2013.168","article-title":"Loss of iron triggers PINK1\/Parkin-independent mitophagy","volume":"14","author":"Allen","year":"2013","unstructured":"PMID: 24176932","journal-title":"EMBO Rep."},{"key":"10.59368\/agingbio.20230010_r32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.phrs.2018.09.006","article-title":"Regulation of ER-mitochondria contacts by Parkin via Mfn2","volume":"138","author":"Basso","year":"2018","unstructured":"PMID: 30219582","journal-title":"Pharmacol. Res."},{"key":"10.59368\/agingbio.20230010_r33","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2020.101772","article-title":"Deep phenotyping of peripheral tissue facilitates mechanistic disease stratification in sporadic Parkinson\u2019s disease","volume":"187","author":"Carling","year":"2020","unstructured":"PMID: 32058042","journal-title":"Prog. Neurobiol."},{"issue":"4","key":"10.59368\/agingbio.20230010_r34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22042215","article-title":"Gba mutations influence the release and pathological effects of small extracellular vesicles from fibroblasts of patients with Parkinson\u2019s disease","volume":"22","author":"Cerri","year":"2021","unstructured":"PMID: 33672321","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.59368\/agingbio.20230010_r35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0183444","article-title":"Mitochondrial superclusters influence age of onset of Parkinson\u2019s disease in a gender specific manner in the Cypriot population: A case-control study","volume":"12","author":"Georgiou","year":"2017","unstructured":"PMID: 28877188","journal-title":"PLoS One"},{"key":"10.59368\/agingbio.20230010_r36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012962","article-title":"Mutant Parkin impairs mitochondrial function and morphology in human fibroblasts","volume":"5","author":"Gr\u00fcnewald","year":"2010","unstructured":"PMID: 20885945","journal-title":"PLoS One"},{"issue":"13","key":"10.59368\/agingbio.20230010_r37","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1089\/ars.2013.5737","article-title":"Does uncoupling protein 2 expression qualify as marker of disease status in LRRK2-associated Parkinson\u2019s disease?","volume":"20","author":"Gr\u00fcnewald","year":"2014","unstructured":"PMID: 24251413","journal-title":"Antioxid. Redox Signal."},{"key":"10.59368\/agingbio.20230010_r38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/embr.201948686","article-title":"PINK 1 phosphorylates Drp1 S616 to regulate mitophagy-independent mitochondrial dynamics","volume":"21","author":"Han","year":"2020","unstructured":"PMID: 32484300","journal-title":"EMBO Rep."},{"issue":"19","key":"10.59368\/agingbio.20230010_r39","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1093\/hmg\/dds244","article-title":"G2019S leucine-rich repeat kinase 2 causes uncoupling protein-mediated mitochondrial depolarization","volume":"21","author":"Papkovskaia","year":"2012","unstructured":"PMID: 22736029","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.59368\/agingbio.20230010_r40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13041-020-00712-3","article-title":"Fibroblasts from idiopathic Parkinson\u2019s disease exhibit deficiency of lysosomal glucocerebrosidase activity associated with reduced levels of the trafficking receptor LIMP2","volume":"14","author":"Thomas","year":"2021","unstructured":"PMID: 33468204","journal-title":"Mol. Brain"},{"issue":"3","key":"10.59368\/agingbio.20230010_r41","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11030373","article-title":"Modelling Parkinson\u2019s disease: iPSCs towards better understanding of human pathology","volume":"11","author":"Avazzadeh","year":"2021","unstructured":"PMID: 33799491","journal-title":"Brain Sci."},{"issue":"12","key":"10.59368\/agingbio.20230010_r42","doi-asserted-by":"publisher","DOI":"10.3390\/cells10123436","article-title":"Mitochondrial phenotypes in Parkinson\u2019s diseases\u2014A focus on human iPSC-derived dopaminergic neurons","volume":"10","author":"Heger","year":"2021","unstructured":"PMID: 34943944","journal-title":"Cells"},{"issue":"2","key":"10.59368\/agingbio.20230010_r43","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/2211-5463.13060","article-title":"Alpha-synuclein dynamics in induced pluripotent stem cell-derived dopaminergic neurons from a Parkinson\u2019s disease patient (PARK4) with SNCA triplication","volume":"11","author":"Fukusumi","year":"2021","unstructured":"PMID: 33301617","journal-title":"FEBS Open Bio"},{"issue":"6","key":"10.59368\/agingbio.20230010_r44","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.stem.2016.08.002","article-title":"Functional impairment in Miro degradation and mitophagy is a shared feature in familial and sporadic Parkinson\u2019s disease","volume":"19","author":"Hsieh","year":"2016","unstructured":"PMID: 27618216","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.59368\/agingbio.20230010_r45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1756-6606-5-35","article-title":"Mitochondrial dysfunction associated with increased oxidative stress and \u03b1-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue","volume":"5","author":"Imaizumi","year":"2012","unstructured":"PMID: 23039195","journal-title":"Mol. Brain"},{"issue":"2","key":"10.59368\/agingbio.20230010_r46","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41591-019-0739-1","article-title":"iPSC modeling of young-onset Parkinson\u2019s disease reveals a molecular signature of disease and novel therapeutic candidates","volume":"26","author":"Laperle","year":"2020","unstructured":"PMID: 31988461","journal-title":"Nat. Med."},{"issue":"1","key":"10.59368\/agingbio.20230010_r47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-23682-z","article-title":"Phenotypic manifestation of \u03b1-synuclein strains derived from Parkinson\u2019s disease and multiple system atrophy in human dopaminergic neurons","volume":"12","author":"Tanudjojo","year":"2021","unstructured":"PMID: 34155194","journal-title":"Nat. Commun."},{"key":"10.59368\/agingbio.20230010_r48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.brainresbull.2020.03.006","article-title":"Parkin mutation decreases neurite complexity and maturation in neurons derived from human fibroblasts","volume":"159","author":"Pu","year":"2020","unstructured":"PMID: 32156628","journal-title":"Brain Res. Bull."},{"issue":"1","key":"10.59368\/agingbio.20230010_r49","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/mds.28786","article-title":"Molecular features of Parkinson\u2019s disease in patient-derived midbrain dopaminergic neurons","volume":"37","author":"Ren","year":"2022","unstructured":"PMID: 34564901","journal-title":"Mov. Disord."},{"issue":"2","key":"10.59368\/agingbio.20230010_r50","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2018.12.011","article-title":"Patient-specific iPSC-derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson\u2019s disease","volume":"12","author":"di Domenico","year":"2019","unstructured":"PMID: 30639209","journal-title":"Stem Cell Reports"},{"issue":"1","key":"10.59368\/agingbio.20230010_r51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-71329-8","article-title":"Metabolic alterations in Parkinson\u2019s disease astrocytes","volume":"10","author":"Sonninen","year":"2020","unstructured":"PMID: 32879386","journal-title":"Sci. Rep."},{"key":"10.59368\/agingbio.20230010_r52","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.brainres.2015.11.013","article-title":"Back and forth in time: Directing age in iPSC-derived lineages","volume":"1656","author":"Cornacchia","year":"2017","unstructured":"PMID: 26592774","journal-title":"Brain Res."},{"issue":"6","key":"10.59368\/agingbio.20230010_r53","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.cell.2013.02.043","article-title":"Epigenetics of reprogramming to induced pluripotency","volume":"152","author":"Papp","year":"2013","unstructured":"PMID: 23498940","journal-title":"Cell"},{"issue":"6","key":"10.59368\/agingbio.20230010_r54","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.stem.2013.11.006","article-title":"Human iPSC-based modeling of late-onset disease via progerin-induced aging","volume":"13","author":"Miller","year":"2013","unstructured":"PMID: 24315443","journal-title":"Cell Stem Cell"},{"key":"10.59368\/agingbio.20230010_r55","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.celrep.2016.09.062","article-title":"Models by inducing neuronal age-related","volume":"17","author":"Vera","year":"2016","unstructured":"PMID: 27760320"},{"key":"10.59368\/agingbio.20230010_r56","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00530","article-title":"Direct neuronal reprogramming for disease modeling studies using patient-derived neurons: What have we learned?","volume":"11","author":"Drouin-Ouellet","year":"2017","unstructured":"PMID: 29033781","journal-title":"Front. Neurosci."},{"key":"10.59368\/agingbio.20230010_r57","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1146\/annurev-genet-120417-031534","article-title":"Aging in a dish: iPSC-derived and directly induced neurons for studying brain aging and age-related neurodegenerative diseases","volume":"52","author":"Mertens","year":"2018","unstructured":"PMID: 30208291","journal-title":"Annu. Rev. Genet."},{"key":"10.59368\/agingbio.20230010_r58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnmol.2017.00359","article-title":"Direct reprogramming rather than iPSC-based reprogramming maintains aging hallmarks in human motor neurons","volume":"10","author":"Tang","year":"2017","unstructured":"PMID: 29163034","journal-title":"Front. Mol. Neurosci."},{"issue":"10","key":"10.59368\/agingbio.20230010_r59","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1016\/j.stemcr.2022.08.010","article-title":"Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson\u2019s disease","volume":"17","author":"Drouin-Ouellet","year":"2022","unstructured":"PMID: 36150382","journal-title":"Stem Cell Reports"},{"issue":"2","key":"10.59368\/agingbio.20230010_r60","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1073\/pnas.1314085111","article-title":"Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS","volume":"111","author":"Meyer","year":"2014","unstructured":"PMID: 24379375","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.59368\/agingbio.20230010_r61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/acel.13281","article-title":"Directly converted astrocytes retain the ageing features of the donor fibroblasts and elucidate the astrocytic contribution to human CNS health and disease","volume":"20","author":"Gatto","year":"2021","unstructured":"PMID: 33314575","journal-title":"Aging Cell"},{"issue":"2","key":"10.59368\/agingbio.20230010_r62","doi-asserted-by":"publisher","DOI":"10.26508\/lsa.202101287","article-title":"Benchmarking a highly selective USP30 inhibitor for enhancement of mitophagy and pexophagy","volume":"5","author":"Rusilowicz-Jones","year":"2022","unstructured":"PMID: 34844982","journal-title":"Life Sci. Alliance"},{"issue":"18","key":"10.59368\/agingbio.20230010_r63","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2015.07.050","article-title":"Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the vulnerability of dopamine neurons","volume":"25","author":"Pacelli","year":"2015","unstructured":"PMID: 26320949","journal-title":"Curr. Biol."},{"issue":"25","key":"10.59368\/agingbio.20230010_r64","doi-asserted-by":"publisher","first-page":"9580","DOI":"10.1074\/jbc.RA117.000499","article-title":"Comparative analysis of Parkinson\u2019s disease\u2013associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons","volume":"293","author":"Gigu\u00e8re","year":"2018","unstructured":"PMID: 29700116","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.59368\/agingbio.20230010_r65","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/bpa.12253","article-title":"Molecular, neurochemical, and behavioral hallmarks of reserpine as a model for Parkinson\u2019s disease: New perspectives to a long-standing model","volume":"25","author":"Le\u00e3o","year":"2015","unstructured":"PMID: 25726735","journal-title":"Brain Pathol."},{"key":"10.59368\/agingbio.20230010_r66","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10123026","article-title":"How well do rodent models of Parkinson\u2019s disease recapitulate early non-motor phenotypes? A systematic review","volume":"10","author":"Zhang","year":"2022","unstructured":"PMID: 36551782","journal-title":"Biomedicines"},{"issue":"4","key":"10.59368\/agingbio.20230010_r67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/NS20210026","article-title":"Animal models of Parkinson\u2019s disease: A guide to selecting the optimal model for your research","volume":"5","author":"Lama","year":"2021","unstructured":"PMID: 34956652","journal-title":"Neuronal Signal."},{"issue":"3","key":"10.59368\/agingbio.20230010_r68","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00702-017-1715-x","article-title":"The use of nonhuman primate models to understand processes in Parkinson\u2019s disease","volume":"125","author":"Blesa","year":"2018","unstructured":"PMID: 28357564","journal-title":"J. Neural Transm."},{"issue":"2","key":"10.59368\/agingbio.20230010_r69","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00702-019-02133-6","article-title":"6-Hydroxydopamine: A far from simple neurotoxin","volume":"127","author":"Vare\u0161lija","year":"2020","unstructured":"PMID: 31894418","journal-title":"J. Neural Transm."},{"issue":"3\u20134","key":"10.59368\/agingbio.20230010_r70","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/BF03033565","article-title":"The 6-hydroxydopamine model of Parkinson\u2019s disease","volume":"11","author":"Simola","year":"2007","unstructured":"PMID: 17449457","journal-title":"Neurotox. Res."},{"issue":"5985","key":"10.59368\/agingbio.20230010_r71","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/311467a0","article-title":"Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase inhibitors","volume":"311","author":"Heikkila","year":"1984","unstructured":"PMID: 6332989","journal-title":"Nature"},{"issue":"3","key":"10.59368\/agingbio.20230010_r72","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0304-3940(87)90543-X","article-title":"Astrocytes convert the Parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+","volume":"75","author":"Ransom","year":"1987","unstructured":"PMID: 3495754","journal-title":"Neurosci. Lett."},{"issue":"8","key":"10.59368\/agingbio.20230010_r73","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/0024-3205(87)90299-2","article-title":"MPTP, MPP+ and mitochondrial function","volume":"40","author":"Nicklas","year":"1987","unstructured":"PMID: 3100899","journal-title":"Life Sci."},{"issue":"3","key":"10.59368\/agingbio.20230010_r74","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson\u2019s disease","volume":"54","author":"Schapira","year":"1990","unstructured":"PMID: 2154550","journal-title":"J. Neurochem."},{"issue":"2","key":"10.59368\/agingbio.20230010_r75","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0024-3205(87)90359-6","article-title":"Differential responsiveness to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in sub-regions of the primate substantia nigra and striatum","volume":"40","author":"Elsworth","year":"1987","unstructured":"PMID: 3491946","journal-title":"Life Sci."},{"issue":"6180","key":"10.59368\/agingbio.20230010_r76","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/334345a0","article-title":"Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson\u2019s disease","volume":"334","author":"Hirsch","year":"1988","unstructured":"PMID: 2899295","journal-title":"Nature"},{"issue":"1","key":"10.59368\/agingbio.20230010_r77","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/0006-8993(87)90691-3","article-title":"Selective loss of subpopulations of ventral mesencephalic dopaminergic neurons in the monkey following exposure to MPTP","volume":"411","author":"Schneider","year":"1987","unstructured":"PMID: 2886180","journal-title":"Brain Res."},{"key":"10.59368\/agingbio.20230010_r78","first-page":"548","article-title":"Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in rat, guinea pig, and monkey","volume":"20","author":"Chiueh","year":"1984","unstructured":"PMID: 6332333","journal-title":"Psychopharmacol. Bull."},{"key":"10.59368\/agingbio.20230010_r79","first-page":"1008","article-title":"Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 2: Central administration of 1-methyl-4-phenylpyridinium","volume":"270","author":"Giovanni","year":"1994","unstructured":"PMID: 7932148","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.59368\/agingbio.20230010_r80","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson\u2019s disease","volume":"2","author":"Jackson-Lewis","year":"2007","unstructured":"PMID: 17401348","journal-title":"Nat. Protoc."},{"issue":"10","key":"10.59368\/agingbio.20230010_r81","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/aps.2017.49","article-title":"Reassessment of subacute MPTP-treated mice as animal model of Parkinson\u2019s disease","volume":"38","author":"Zhang","year":"2017","unstructured":"PMID: 28649132","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.59368\/agingbio.20230010_r82","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1172\/JCI43871","article-title":"Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients","volume":"121","author":"She","year":"2011","unstructured":"PMID: 21393861","journal-title":"J. Clin. Invest."},{"key":"10.59368\/agingbio.20230010_r83","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.neuro.2017.03.008","article-title":"Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss","volume":"60","author":"Alam","year":"2017","unstructured":"PMID: 28377118","journal-title":"Neurotoxicology"},{"issue":"6","key":"10.59368\/agingbio.20230010_r84","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: Mechanisms and models","volume":"39","author":"Dauer","year":"2003","unstructured":"PMID: 12971891","journal-title":"Neuron"},{"issue":"3","key":"10.59368\/agingbio.20230010_r85","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ntt.2011.02.012","article-title":"Genetic-based, differential susceptibility to paraquat neurotoxicity in mice","volume":"33","author":"Yin","year":"2011","unstructured":"PMID: 21371552","journal-title":"Neurotoxicol. Teratol."},{"issue":"4","key":"10.59368\/agingbio.20230010_r86","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/j.1471-4159.2005.03088.x","article-title":"Role of oxidative stress in paraquat-induced dopaminergic cell degeneration","volume":"93","author":"McCormack","year":"2005","unstructured":"PMID: 15857406","journal-title":"J. Neurochem."},{"issue":"10","key":"10.59368\/agingbio.20230010_r87","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164094","article-title":"Assessment of the effects of MPTP and paraquat on dopaminergic neurons and microglia in the substantia nigra pars compacta of C57BL\/6 mice","volume":"11","author":"Smeyne","year":"2016","unstructured":"PMID: 27788145","journal-title":"PLoS One"},{"issue":"2","key":"10.59368\/agingbio.20230010_r88","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1006\/nbdi.2002.0507","article-title":"Environmental risk factors and Parkinson\u2019s disease: Selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat","volume":"10","author":"McCormack","year":"2002","unstructured":"PMID: 12127150","journal-title":"Neurobiol. Dis."},{"issue":"3","key":"10.59368\/agingbio.20230010_r89","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1046\/j.1460-9568.2003.02781.x","article-title":"Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson\u2019s disease phenotype","volume":"18","author":"Thiruchelvam","year":"2003","unstructured":"PMID: 12911755","journal-title":"Eur. J. Neurosci."},{"issue":"3","key":"10.59368\/agingbio.20230010_r90","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1074\/jbc.C100560200","article-title":"The herbicide paraquat causes up-regulation and aggregation of alpha-synuclein in mice: paraquat and alpha-synuclein","volume":"277","author":"Manning-Bog","year":"2002","unstructured":"PMID: 11707429","journal-title":"J. Biol. Chem."},{"issue":"18","key":"10.59368\/agingbio.20230010_r91","doi-asserted-by":"publisher","first-page":"13621","DOI":"10.1074\/jbc.M109.074617","article-title":"Lysosomal degradation of \u03b1-synuclein in vivo","volume":"285","author":"Mak","year":"2010","unstructured":"PMID: 20200163","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.59368\/agingbio.20230010_r92","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.1523\/JNEUROSCI.23-08-03095.2003","article-title":"\u03b1-synuclein overexpression protects against paraquat-induced neurodegeneration","volume":"23","author":"Manning-Bo\u011f","year":"2003","unstructured":"PMID: 12716914","journal-title":"J. Neurosci."},{"key":"10.59368\/agingbio.20230010_r93","first-page":"1357","article-title":"Paraquat induces selective dopaminergic nigrostriatal degeneration in aging C57BL\/6 mice","volume":"118","author":"Li","year":"2005","unstructured":"PMID: 16157030","journal-title":"Chin. Med. J. (Engl)."},{"issue":"4","key":"10.59368\/agingbio.20230010_r94","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1460-9568.2008.06371.x","article-title":"Cyclooxygenase-2 deficiency modifies the neurochemical effects, motor impairment and co-morbid anxiety provoked by paraquat administration in mice","volume":"28","author":"Litteljohn","year":"2008","unstructured":"PMID: 18657183","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.59368\/agingbio.20230010_r95","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/j.neuroscience.2009.09.025","article-title":"Interferon-\u03b3 deficiency modifies the motor and co-morbid behavioral pathology and neurochemical changes provoked by the pesticide paraquat","volume":"164","author":"Litteljohn","year":"2009","unstructured":"PMID: 19782123","journal-title":"Neuroscience"},{"issue":"11","key":"10.59368\/agingbio.20230010_r96","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson\u2019s disease","volume":"24","author":"Barone","year":"2009","unstructured":"PMID: 19514014","journal-title":"Mov. Disord."},{"issue":"4","key":"10.59368\/agingbio.20230010_r97","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1074\/jbc.M708597200","article-title":"Complex I is the major site of mitochondrial superoxide production by paraquat","volume":"283","author":"Cochem\u00e9","year":"2008","unstructured":"PMID: 18039652","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.59368\/agingbio.20230010_r98","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0895-3988(08)60035-5","article-title":"Catalytic metalloporphyrin protects against paraquat neurotoxicity in vivo","volume":"21","author":"Chen","year":"2008","unstructured":"PMID: 18714822","journal-title":"Biomed. Environ. Sci."},{"key":"10.59368\/agingbio.20230010_r99","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.brainres.2008.12.033","article-title":"Paraquat is excluded by the blood brain barrier in rhesus macaque: An in vivo pet study","volume":"1259","author":"Bartlett","year":"2009","unstructured":"PMID: 19135428","journal-title":"Brain Res."},{"issue":"6","key":"10.59368\/agingbio.20230010_r100","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/ana.22629","article-title":"Solvent exposures and Parkinson disease risk in twins","volume":"71","author":"Goldman","year":"2012","unstructured":"PMID: 22083847","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.59368\/agingbio.20230010_r101","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/(SICI)1097-0290(19990120)62:2<160::AID-BIT5>3.0.CO;2-4","article-title":"Reductive dechlorination of chlorinated ethene DNAPLs by a culture enriched from contaminated groundwater","volume":"62","author":"Nielsen","year":"1999","unstructured":"PMID: 10099525","journal-title":"Biotechnol. Bioeng."},{"issue":"3","key":"10.59368\/agingbio.20230010_r102","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/j.1471-4159.2009.06497.x","article-title":"Trichloroethylene induces dopaminergic neurodegeneration in Fisher 344 rats","volume":"112","author":"Liu","year":"2010","unstructured":"PMID: 19922440","journal-title":"J. Neurochem."},{"key":"10.59368\/agingbio.20230010_r103","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105312","article-title":"The industrial solvent trichloroethylene induces LRRK2 kinase activity and dopaminergic neurodegeneration in a rat model of Parkinson\u2019s disease","volume":"153","author":"De Miranda","year":"2021","unstructured":"PMID: 33636387","journal-title":"Neurobiol. Dis."},{"issue":"7","key":"10.59368\/agingbio.20230010_r104","doi-asserted-by":"publisher","first-page":"6201","DOI":"10.1007\/s12035-017-0830-x","article-title":"Trichloroethylene and Parkinson\u2019s disease: Risk assessment","volume":"55","author":"Liu","year":"2018","unstructured":"PMID: 29270919","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.59368\/agingbio.20230010_r105","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/jat.3708","article-title":"Irreversible effects of trichloroethylene on the gut microbial community and gut-associated immune responses in autoimmune-prone mice","volume":"39","author":"Khare","year":"2019","unstructured":"PMID: 30187502","journal-title":"J. Appl. Toxicol."},{"key":"10.59368\/agingbio.20230010_r106","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S1353-8020(03)00023-3","article-title":"The rotenone model of Parkinson\u2019s disease: Genes, environment and mitochondria","volume":"9","author":"Greenamyre","year":"2003","unstructured":"PMID: 12915069","journal-title":"Parkinsonism Relat. Disord."},{"issue":"1","key":"10.59368\/agingbio.20230010_r107","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/toxsci\/kfz082","article-title":"Sex differences in rotenone sensitivity reflect the male-to-female ratio in human Parkinson\u2019s disease incidence","volume":"170","author":"De Miranda","year":"2019","unstructured":"PMID: 30907971","journal-title":"Toxicol. Sci."},{"key":"10.59368\/agingbio.20230010_r108","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104626","article-title":"LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson\u2019s disease","volume":"134","author":"Rocha","year":"2020","unstructured":"PMID: 31618685","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.59368\/agingbio.20230010_r109","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.tips.2009.12.006","article-title":"Lessons from the rotenone model of Parkinson\u2019s disease","volume":"31","author":"Greenamyre","year":"2010","unstructured":"PMID: 20096940","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.59368\/agingbio.20230010_r110","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","article-title":"A highly reproducible rotenone model of Parkinson\u2019s disease","volume":"34","author":"Cannon","year":"2009","unstructured":"PMID: 19385059","journal-title":"Neurobiol. Dis."},{"issue":"22","key":"10.59368\/agingbio.20230010_r111","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.1523\/JNEUROSCI.2770-20.2021","article-title":"VGLUT2 is a determinant of dopamine neuron resilience in a rotenone model of dopamine neurodegeneration","volume":"41","author":"Buck","year":"2021","unstructured":"PMID: 33893220","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"18","key":"10.59368\/agingbio.20230010_r112","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.cub.2015.07.050","article-title":"Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the vulnerability of dopamine neurons","volume":"25","author":"Pacelli","year":"2015","unstructured":"PMID: 26320949","journal-title":"Curr. Biol."},{"issue":"12","key":"10.59368\/agingbio.20230010_r113","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease","volume":"3","author":"Betarbet","year":"2000","unstructured":"PMID: 11100151","journal-title":"Nat. Neurosci."},{"issue":"2","key":"10.59368\/agingbio.20230010_r114","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.brainres.2005.02.036","article-title":"Sleep disturbances in the rotenone animal model of Parkinson disease","volume":"1042","author":"Garc\u00eda-Garc\u00eda","year":"2005","unstructured":"PMID: 15854587","journal-title":"Brain Res."},{"issue":"1","key":"10.59368\/agingbio.20230010_r115","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.nbd.2009.06.017","article-title":"Chronic rotenone exposure reproduces Parkinson\u2019s disease gastrointestinal neuropathology","volume":"36","author":"Drolet","year":"2009","unstructured":"PMID: 19595768","journal-title":"Neurobiol. Dis."},{"key":"10.59368\/agingbio.20230010_r116","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105685","article-title":"Rotenone induces regionally distinct \u03b1-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl\/6 mice","volume":"167","author":"Rocha","year":"2022","unstructured":"PMID: 35257879","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.59368\/agingbio.20230010_r117","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1046\/j.1471-4159.1998.70041584.x","article-title":"Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system","volume":"70","author":"Casta\u00f1o","year":"1998","unstructured":"PMID: 9580157","journal-title":"J. Neurochem."},{"issue":"25","key":"10.59368\/agingbio.20230010_r118","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1403215111","article-title":"Abrogation of -synuclein-mediated dopaminergic neurodegeneration in LRRK2-deficient rats","volume":"111","author":"Daher","year":"2014","unstructured":"PMID: 24927544","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.59368\/agingbio.20230010_r119","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0306-4522(90)90229-W","article-title":"Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain","volume":"39","author":"Lawson","year":"1990","unstructured":"PMID: 2089275","journal-title":"Neuroscience"},{"issue":"4","key":"10.59368\/agingbio.20230010_r120","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1006\/nbdi.2000.0289","article-title":"The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system","volume":"7","author":"Herrera","year":"2000","unstructured":"PMID: 10964613","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.59368\/agingbio.20230010_r121","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/j.1471-4159.2006.04327.x","article-title":"Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system","volume":"100","author":"Hunter","year":"2007","unstructured":"PMID: 17254027","journal-title":"J. Neurochem."},{"key":"10.59368\/agingbio.20230010_r122","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.bbrc.2021.11.008","article-title":"Ex vivo imaging and analysis of ROS generation correlated with microglial activation in rat model with acute neuroinflammation induced by intrastriatal injection of LPS","volume":"584","author":"Shukuri","year":"2021","unstructured":"PMID: 34781201","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.59368\/agingbio.20230010_r123","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.brainres.2014.02.005","article-title":"Short-term effects of an endotoxin on substantia nigra dopamine neurons","volume":"1557","author":"Reinert","year":"2014","unstructured":"PMID: 24513404","journal-title":"Brain Res."},{"issue":"25","key":"10.59368\/agingbio.20230010_r124","doi-asserted-by":"publisher","first-page":"8546","DOI":"10.1523\/JNEUROSCI.5002-13.2014","article-title":"Neurodegeneration by activation of the microglial complement-phagosome pathway","volume":"34","author":"Bodea","year":"2014","unstructured":"PMID: 24948809","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"8","key":"10.59368\/agingbio.20230010_r125","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/mds.25736","article-title":"Progression of intestinal permeability changes and alpha-synuclein expression in a mouse model of Parkinson\u2019s disease","volume":"29","author":"Kelly","year":"2014","unstructured":"PMID: 24898698","journal-title":"Mov. Disord."},{"issue":"4","key":"10.59368\/agingbio.20230010_r126","doi-asserted-by":"publisher","first-page":"2653","DOI":"10.1007\/s12035-018-1235-1","article-title":"Loss of brain norepinephrine elicits neuroinflammation-mediated oxidative injury and selective caudo-rostral neurodegeneration","volume":"56","author":"Song","year":"2019","unstructured":"PMID: 30051353","journal-title":"Mol. Neurobiol."},{"issue":"5","key":"10.59368\/agingbio.20230010_r127","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s11011-015-9698-5","article-title":"Lipoic acid protects dopaminergic neurons in LPS-induced Parkinson\u2019s disease model","volume":"30","author":"Li","year":"2015","unstructured":"PMID: 26084861","journal-title":"Metab. Brain Dis."},{"issue":"11","key":"10.59368\/agingbio.20230010_r128","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078418","article-title":"Intranasal LPS-mediated Parkinson\u2019s model challenges the pathogenesis of nasal cavity and environmental toxins","volume":"8","author":"He","year":"2013","unstructured":"PMID: 24250796","journal-title":"PLoS One"},{"key":"10.59368\/agingbio.20230010_r129","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fncel.2021.658244","article-title":"Striatal dopamine transporter function is facilitated by converging biology of \u03b1-synuclein and cholesterol","volume":"15","author":"Threlfell","year":"2021","unstructured":"PMID: 33935654","journal-title":"Front. Cell. Neurosci."},{"issue":"51","key":"10.59368\/agingbio.20230010_r130","doi-asserted-by":"publisher","first-page":"32701","DOI":"10.1073\/pnas.2013652117","article-title":"A dual role for \u03b1-synuclein in facilitation and depression of dopamine release from substantia nigra neurons in vivo","volume":"117","author":"Somayaji","year":"2020","unstructured":"PMID: 33273122","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.59368\/agingbio.20230010_r131","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/nrn.2017.75","article-title":"Animal models of \u03b1-synucleinopathy for Parkinson disease drug development","volume":"18","author":"Koprich","year":"2017","unstructured":"PMID: 28747776","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.59368\/agingbio.20230010_r132","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s13311-012-0104-2","article-title":"A progressive mouse model of Parkinson\u2019s disease: The Thy1-aSyn (\u201cLine 61\u201d) mice","volume":"9","author":"Chesselet","year":"2012","unstructured":"PMID: 22350713","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.59368\/agingbio.20230010_r133","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.nbd.2012.04.009","article-title":"Alpha-synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits","volume":"47","author":"Hallett","year":"2012","unstructured":"PMID: 22549133","journal-title":"Neurobiol. Dis."},{"issue":"13","key":"10.59368\/agingbio.20230010_r134","doi-asserted-by":"publisher","first-page":"8968","DOI":"10.1073\/pnas.132197599","article-title":"Human alpha-synuclein-harboring familial Parkinson\u2019s disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice","volume":"99","author":"Lee","year":"2002","unstructured":"PMID: 12084935","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5456","key":"10.59368\/agingbio.20230010_r135","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in \u03b1-synuclein mice: Implications for neurodegenerative disorders","volume":"287","author":"Masliah","year":"2000","unstructured":"PMID: 10678833","journal-title":"Science"},{"key":"10.59368\/agingbio.20230010_r136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2021.760781","article-title":"Transgenic mice expressing human \u03b1-synuclein 1-103 fragment as a novel model of Parkinson\u2019s disease","volume":"13","author":"Tian","year":"2021","unstructured":"PMID: 34744697","journal-title":"Front. Aging Neurosci."},{"issue":"42","key":"10.59368\/agingbio.20230010_r137","doi-asserted-by":"publisher","first-page":"E4016","DOI":"10.1073\/pnas.1309143110","article-title":"Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model","volume":"110","author":"Janezic","year":"2013","unstructured":"PMID: 24082145","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.59368\/agingbio.20230010_r138","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1523\/JNEUROSCI.0089-14.2015","article-title":"A53T human \u03b1-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration","volume":"35","author":"Chen","year":"2015","unstructured":"PMID: 25609609","journal-title":"J. Neurosci."},{"issue":"1","key":"10.59368\/agingbio.20230010_r139","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/nan.12298","article-title":"Review: Sporadic Parkinson\u2019s disease: Development and distribution of \u03b1-synuclein pathology","volume":"42","author":"Del Tredici","year":"2016","unstructured":"PMID: 26662475","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"1","key":"10.59368\/agingbio.20230010_r140","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.expneurol.2009.07.025","article-title":"Alpha-synuclein immunopositive aggregates in the myenteric plexus of the aging Fischer 344 rat","volume":"220","author":"Phillips","year":"2009","unstructured":"PMID: 19664623","journal-title":"Exp. Neurol."},{"issue":"10","key":"10.59368\/agingbio.20230010_r141","doi-asserted-by":"publisher","first-page":"5864","DOI":"10.1128\/IAI.68.10.5864-5868.2000","article-title":"Genetic control of susceptibility to Porphyromonas gingivalis-induced alveolar bone loss in mice","volume":"68","author":"Baker","year":"2000","unstructured":"PMID: 10992496","journal-title":"Infect. Immun."},{"issue":"1","key":"10.59368\/agingbio.20230010_r142","doi-asserted-by":"publisher","DOI":"10.1038\/srep34477","article-title":"Exposure to the functional bacterial amyloid protein curli enhances alpha-synuclein aggregation in aged Fischer 344 rats and caenorhabditis elegans","volume":"6","author":"Chen","year":"2016","unstructured":"PMID: 27708338","journal-title":"Sci. Rep."},{"issue":"6","key":"10.59368\/agingbio.20230010_r143","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","article-title":"Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease","volume":"167","author":"Sampson","year":"2016","unstructured":"PMID: 27912057","journal-title":"Cell"},{"key":"10.59368\/agingbio.20230010_r144","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.neuron.2017.09.036.Age-dependent","article-title":"\u4e73\u9f20\u5fc3\u808c\u63d0\u53d6 HHS public access.","volume":"176","author":"Liu","year":"2017","journal-title":"Physiol. Behav."},{"issue":"2","key":"10.59368\/agingbio.20230010_r145","doi-asserted-by":"publisher","first-page":"569","DOI":"10.3233\/JPD-202172","article-title":"Combined knockout of LRRK2 and RAB29 does not result in behavioral abnormalities in vivo","volume":"11","author":"Mazza","year":"2021","unstructured":"PMID: 33523017","journal-title":"J. Parkinsons. Dis."},{"issue":"5","key":"10.59368\/agingbio.20230010_r146","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1093\/hmg\/ddv628","article-title":"LRRK2 BAC transgenic rats develop progressive, L-DOPA-responsive motor impairment, and deficits in dopamine circuit function","volume":"25","author":"Sloan","year":"2016","unstructured":"PMID: 26744332","journal-title":"Hum. Mol. Genet."},{"issue":"4","key":"10.59368\/agingbio.20230010_r147","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018568","article-title":"Dopaminergic neuronal loss, reduced neurite complexity and autophagic abnormalities in transgenic mice expressing G2019S mutant LRRK2","volume":"6","author":"Ramonet","year":"2011","unstructured":"PMID: 21494637","journal-title":"PLoS One"},{"issue":"5","key":"10.59368\/agingbio.20230010_r148","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1523\/JNEUROSCI.5604-09.2010","article-title":"Enhanced striatal dopamine transmission and motor performance with LRRK2 overexpression in mice is eliminated by familial Parkinson\u2019s disease mutation G2019S","volume":"30","author":"Li","year":"2010","unstructured":"PMID: 20130188","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.59368\/agingbio.20230010_r149","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.nbd.2015.02.031","article-title":"Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice","volume":"78","author":"Yue","year":"2015","unstructured":"PMID: 25836420","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.59368\/agingbio.20230010_r150","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-017-0426-8","article-title":"Age-dependent dopamine transporter dysfunction and Serine129 phospho-\u03b1-synuclein overload in G2019S LRRK2 mice.","volume":"5","author":"Longo","year":"2017","unstructured":"PMID: 28292328","journal-title":"Acta Neuropathol. Commun."},{"issue":"6","key":"10.59368\/agingbio.20230010_r151","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252325","article-title":"Decreased glucocerebrosidase activity and substrate accumulation of glycosphingolipids in a novel GBA1 D409V knock-in mouse model","volume":"16","author":"Polinski","year":"2021","unstructured":"PMID: 34106956","journal-title":"PLoS One"},{"key":"10.59368\/agingbio.20230010_r152","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2019.104502","article-title":"Age-related neurochemical and behavioural changes in D409V\/WT GBA1 mouse: Relevance to Lewy body dementia","volume":"129","author":"Clarke","year":"2019","unstructured":"PMID: 31299418","journal-title":"Neurochem. Int."},{"key":"10.59368\/agingbio.20230010_r153","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105513","article-title":"Heterozygous GBA D490V and ATP13a2 mutations do not exacerbate pathological \u03b1-synuclein spread in the prodromal preformed fibrils model in young mice","volume":"159","author":"Johnson","year":"2021","unstructured":"PMID: 34536552","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.59368\/agingbio.20230010_r154","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-017-0233-5","article-title":"\u03b1-synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced Parkinsonism","volume":"13","author":"Yun","year":"2018","unstructured":"PMID: 29310663","journal-title":"Mol. Neurodegener."},{"issue":"4","key":"10.59368\/agingbio.20230010_r155","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ymgme.2017.11.001","article-title":"Glucocerebrosidase haploinsufficiency in A53T \u03b1-synuclein mice impacts disease onset and course","volume":"122","author":"Tayebi","year":"2017","unstructured":"PMID: 29173981","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.59368\/agingbio.20230010_r156","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1073\/pnas.0605208103","article-title":"Progressive Parkinsonism in mice with respiratory-chain-deficient dopamine neurons","volume":"104","author":"Ekstrand","year":"2007","unstructured":"PMID: 17227870","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.59368\/agingbio.20230010_r157","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1601-183X.2009.00542.x","article-title":"MitoPark mice mirror the slow progression of key symptoms and L-DOPA response in Parkinson\u2019s disease","volume":"9","author":"Galter","year":"2010","unstructured":"PMID: 20002202","journal-title":"Genes. Brain. Behav."},{"issue":"8","key":"10.59368\/agingbio.20230010_r158","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0071341","article-title":"Cognitive dysfunction precedes the onset of motor symptoms in the MitoPark mouse model of Parkinson\u2019s disease","volume":"8","author":"Li","year":"2013","unstructured":"PMID: 23977020","journal-title":"PLoS One"},{"key":"10.59368\/agingbio.20230010_r159","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.nbd.2014.08.024","article-title":"Loss of dopamine disrupts circadian rhythms in a mouse model of Parkinson\u2019s disease","volume":"71","author":"Fifel","year":"2014","unstructured":"PMID: 25171792","journal-title":"Neurobiol. Dis."},{"key":"10.59368\/agingbio.20230010_r160","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.neuro.2019.09.004","article-title":"MitoPark transgenic mouse model recapitulates the gastrointestinal dysfunction and gut-microbiome changes of Parkinson\u2019s disease","volume":"75","author":"Ghaisas","year":"2019","unstructured":"PMID: 31505196","journal-title":"Neurotoxicology"},{"key":"10.59368\/agingbio.20230010_r161","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105768","article-title":"Understanding the contributions of VPS35 and the retromer in neurodegenerative disease","volume":"170","author":"Williams","year":"2022","unstructured":"PMID: 35588987","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.59368\/agingbio.20230010_r162","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1083\/jcb.201105109","article-title":"VPS35 haploinsufficiency increases Alzheimer\u2019s disease neuropathology","volume":"195","author":"Wen","year":"2011","unstructured":"PMID: 22105352","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.59368\/agingbio.20230010_r163","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ajhg.2011.06.001","article-title":"VPS35 mutations in Parkinson disease","volume":"89","author":"Vilari\u00f1o-G\u00fcell","year":"2011","unstructured":"PMID: 21763482","journal-title":"Am. J. Hum. Genet."},{"issue":"1","key":"10.59368\/agingbio.20230010_r164","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.ajhg.2011.06.008","article-title":"A mutation in VPS35, encoding a subunit of the retromer complex, causes late-onset Parkinson disease","volume":"89","author":"Zimprich","year":"2011","unstructured":"PMID: 21763483","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"10.59368\/agingbio.20230010_r165","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/mds.24927","article-title":"The Asp620asn mutation in VPS35 is not a common cause of familial Parkinson\u2019s disease","volume":"27","author":"Guella","year":"2012","unstructured":"PMID: 22278960","journal-title":"Mov. Disord."},{"issue":"10","key":"10.59368\/agingbio.20230010_r166","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/archneurol.2011.3367","article-title":"Frequency of the D620N mutation in VPS35 in Parkinson disease","volume":"69","author":"Kumar","year":"2012","unstructured":"PMID: 22801713","journal-title":"Arch. Neurol."},{"issue":"12","key":"10.59368\/agingbio.20230010_r167","doi-asserted-by":"publisher","first-page":"5765","DOI":"10.1073\/pnas.1814909116","article-title":"Parkinson\u2019s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration","volume":"116","author":"Chen","year":"2019","unstructured":"PMID: 30842285","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.59368\/agingbio.20230010_r168","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13041-020-00704-3","article-title":"Altered striatal dopamine levels in Parkinson\u2019s disease VPS35 D620N mutant transgenic aged mice","volume":"13","author":"Vanan","year":"2020","unstructured":"PMID: 33261640","journal-title":"Mol. Brain"},{"issue":"29","key":"10.59368\/agingbio.20230010_r169","doi-asserted-by":"publisher","first-page":"10613","DOI":"10.1523\/JNEUROSCI.0042-15.2015","article-title":"VPS35 in dopamine neurons is required for endosome-to-golgi retrieval of Lamp2a, a receptor of chaperone-mediated autophagy that is critical for \u03b1-synuclein degradation and prevention of pathogenesis of Parkinson\u2019s disease","volume":"35","author":"Tang","year":"2015","unstructured":"PMID: 26203154","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.59368\/agingbio.20230010_r170","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s10072-003-0108-0","article-title":"DJ-1(PARK7), a novel gene for autosomal recessive, early onset Parkinsonism.","volume":"24","author":"Bonifati","year":"2003","unstructured":"PMID: 14598065","journal-title":"Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"issue":"2","key":"10.59368\/agingbio.20230010_r171","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/ana.10663","article-title":"Early-onset Parkinson\u2019s disease caused by a compound heterozygous DJ-1 mutation","volume":"54","author":"Hague","year":"2003","unstructured":"PMID: 12891685","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.59368\/agingbio.20230010_r172","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/sj.embor.7400074","article-title":"DJ-1 has a role in antioxidative stress to prevent cell death","volume":"5","author":"Taira","year":"2004","unstructured":"PMID: 14749723","journal-title":"EMBO Rep."},{"issue":"41","key":"10.59368\/agingbio.20230010_r173","doi-asserted-by":"publisher","first-page":"15091","DOI":"10.1073\/pnas.0607260103","article-title":"DJ-1, a cancer- and Parkinson\u2019s disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2","volume":"103","author":"Clements","year":"2006","unstructured":"PMID: 17015834","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"4","key":"10.59368\/agingbio.20230010_r174","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/jmcb\/mjs025","article-title":"Age- and diet-dependent requirement of DJ-1 for glucose homeostasis in mice with implications for human type 2 diabetes","volume":"4","author":"Jain","year":"2012","unstructured":"PMID: 22611253","journal-title":"J. Mol. Cell Biol."},{"issue":"22","key":"10.59368\/agingbio.20230010_r175","doi-asserted-by":"publisher","first-page":"21418","DOI":"10.1074\/jbc.M413955200","article-title":"Age-dependent motor deficits and dopaminergic dysfunction in DJ-1 null mice","volume":"280","author":"Chen","year":"2005","unstructured":"PMID: 15799973","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.59368\/agingbio.20230010_r176","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.neuron.2005.01.041","article-title":"Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1","volume":"45","author":"Goldberg","year":"2005","unstructured":"PMID: 15721235","journal-title":"Neuron"},{"issue":"10","key":"10.59368\/agingbio.20230010_r177","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.febslet.2013.04.001","article-title":"Evidence of oxidative stress in young and aged DJ-1-deficient mice","volume":"587","author":"Raman","year":"2013","unstructured":"PMID: 23587484","journal-title":"FEBS Lett."},{"issue":"1","key":"10.59368\/agingbio.20230010_r178","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1750-1326-2-10","article-title":"Absence of dopaminergic neuronal degeneration and oxidative damage in aged DJ-1-deficient mice","volume":"2","author":"Yamaguchi","year":"2007","unstructured":"PMID: 17535435","journal-title":"Mol. Neurodegener."},{"issue":"39","key":"10.59368\/agingbio.20230010_r179","doi-asserted-by":"publisher","first-page":"15918","DOI":"10.1073\/pnas.1205102109","article-title":"Progressive dopaminergic cell loss with unilateral-to-bilateral progression in a genetic model of Parkinson disease","volume":"109","author":"Rousseaux","year":"2012","unstructured":"PMID: 23019375","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"6676","key":"10.59368\/agingbio.20230010_r180","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the Parkin gene cause autosomal recessive juvenile Parkinsonism","volume":"392","author":"Kitada","year":"1998","unstructured":"PMID: 9560156","journal-title":"Nature"},{"key":"10.59368\/agingbio.20230010_r181","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1007\/s100720200097","article-title":"PARK6 is a common cause of familial Parkinsonism.","volume":"23 Suppl 2","author":"Valente","year":"2002","unstructured":"PMID: 12548371","journal-title":"Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"key":"10.59368\/agingbio.20230010_r182","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s100720170063","article-title":"Identification of a novel primary torsion dystonia locus (DYT13) on chromosome 1p36 in an Italian family with cranial-cervical or upper limb onset","volume":"22","author":"Valente","year":"2001","unstructured":"PMID: 11487218","journal-title":"Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"issue":"6","key":"10.59368\/agingbio.20230010_r183","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1001\/archneurol.2010.95","article-title":"Predictors of Parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study","volume":"67","author":"Marder","year":"2010","unstructured":"PMID: 20558392","journal-title":"Arch. Neurol."},{"issue":"44","key":"10.59368\/agingbio.20230010_r184","doi-asserted-by":"publisher","first-page":"43628","DOI":"10.1074\/jbc.M308947200","article-title":"Parkin-deficient mice exhibit nigrostriatal deficits but not loss of dopaminergic neurons","volume":"278","author":"Goldberg","year":"2003","unstructured":"PMID: 12930822","journal-title":"J. Biol. Chem."},{"issue":"18","key":"10.59368\/agingbio.20230010_r185","doi-asserted-by":"publisher","first-page":"18614","DOI":"10.1074\/jbc.M401135200","article-title":"Mitochondrial dysfunction and oxidative damage in Parkin-deficient mice","volume":"279","author":"Palacino","year":"2004","unstructured":"PMID: 14985362","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.59368\/agingbio.20230010_r186","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1073\/pnas.0409598102","article-title":"Parkin-deficient mice are not a robust model of Parkinsonism","volume":"102","author":"Perez","year":"2005","unstructured":"PMID: 15684050","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.59368\/agingbio.20230010_r187","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1002\/jnr.21032","article-title":"Decline of striatal dopamine release in Parkin-deficient mice shown by ex vivo autoradiography","volume":"84","author":"Sato","year":"2006","unstructured":"PMID: 16941649","journal-title":"J. Neurosci. Res."},{"issue":"29","key":"10.59368\/agingbio.20230010_r188","doi-asserted-by":"publisher","first-page":"10744","DOI":"10.1073\/pnas.0401297101","article-title":"Loss of locus coeruleus neurons and reduced startle in Parkin null mice.","volume":"101","author":"Von Coelln","year":"2004","unstructured":"PMID: 15249681","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.59368\/agingbio.20230010_r189","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2015.06.034","article-title":"Endogenous Parkin preserves dopaminergic substantia nigral neurons following mitochondrial dna mutagenic stress","volume":"87","author":"Pickrell","year":"2015","unstructured":"PMID: 26182419","journal-title":"Neuron"},{"issue":"27","key":"10.59368\/agingbio.20230010_r190","doi-asserted-by":"publisher","first-page":"11441","DOI":"10.1073\/pnas.0702717104","article-title":"Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice.","volume":"104","author":"Kitada","year":"2007","unstructured":"PMID: 17563363","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.59368\/agingbio.20230010_r191","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2017.12.002","article-title":"Characterization of early-onset motor deficits in the Pink1-\/- mouse model of Parkinson disease","volume":"1680","author":"Kelm-Nelson","year":"2018","unstructured":"PMID: 29229503","journal-title":"Brain Res."},{"issue":"32","key":"10.59368\/agingbio.20230010_r192","doi-asserted-by":"publisher","first-page":"11364","DOI":"10.1073\/pnas.0802076105","article-title":"Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress","volume":"105","author":"Gautier","year":"2008","unstructured":"PMID: 18687901","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.59368\/agingbio.20230010_r193","doi-asserted-by":"publisher","first-page":"e16038","DOI":"10.1371\/journal.pone.0016038","article-title":"Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice","volume":"6","author":"Akundi","year":"2011","unstructured":"PMID: 21249202","journal-title":"PLoS One"},{"issue":"3","key":"10.59368\/agingbio.20230010_r194","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1111\/j.1471-4159.2009.06350.x","article-title":"Absence of nigral degeneration in aged Parkin\/DJ-1\/PINK1 triple knockout mice","volume":"111","author":"Kitada","year":"2009","unstructured":"PMID: 19694908","journal-title":"J. Neurochem."},{"issue":"20","key":"10.59368\/agingbio.20230010_r195","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1093\/hmg\/ddm083","article-title":"Mono- and double-mutant mouse models of Parkinson\u2019s disease display severe mitochondrial damage","volume":"16","author":"Stichel","year":"2007","unstructured":"PMID: 17412759","journal-title":"Hum. Mol. Genet."},{"key":"10.59368\/agingbio.20230010_r196","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3233\/JPD-2011-11041","article-title":"Loss-of-function rodent models for Parkin and PINK1","volume":"1","author":"Oliveras-Salv\u00e1","year":"2011","unstructured":"PMID: 23939304","journal-title":"J. Parkinsons. Dis."},{"issue":"12","key":"10.59368\/agingbio.20230010_r197","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004863","article-title":"Rgs6 is required for adult maintenance of dopaminergic neurons in the ventral substantia nigra","volume":"10","author":"Bifsha","year":"2014","unstructured":"PMID: 25501001","journal-title":"PLoS Genet."},{"issue":"13","key":"10.59368\/agingbio.20230010_r198","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.126769","article-title":"Age-dependent nigral dopaminergic neurodegeneration and \u03b1-synuclein accumulation in RGS6-deficient mice","volume":"4","author":"Luo","year":"2019","unstructured":"PMID: 31120439","journal-title":"JCI Insight"},{"issue":"11","key":"10.59368\/agingbio.20230010_r199","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1523\/JNEUROSCI.5427-08.2009","article-title":"Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alpha-synucleinopathy","volume":"29","author":"Chung","year":"2009","unstructured":"PMID: 19295143","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"7","key":"10.59368\/agingbio.20230010_r200","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","article-title":"Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system","volume":"22","author":"Kirik","year":"2002","unstructured":"PMID: 11923443","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"2","key":"10.59368\/agingbio.20230010_r201","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1471-4159.2004.02728.x","article-title":"Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: Resemblance to pathogenetic changes in Parkinson\u2019s disease","volume":"91","author":"Yamada","year":"2004","unstructured":"PMID: 15447678","journal-title":"J. Neurochem."},{"issue":"3","key":"10.59368\/agingbio.20230010_r202","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.nbd.2011.12.013","article-title":"Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of \u03b1-synuclein in midbrain dopamine neurons","volume":"45","author":"Decressac","year":"2012","unstructured":"PMID: 22182688","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.59368\/agingbio.20230010_r203","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1007\/s12035-015-9173-7","article-title":"Treatment with trehalose prevents behavioral and neurochemical deficits produced in an AAV \u03b1-synuclein rat model of Parkinson\u2019s disease","volume":"53","author":"He","year":"2016","unstructured":"PMID: 25972237","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.59368\/agingbio.20230010_r204","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1750-1326-5-43","article-title":"Expression of human A53T alpha-synuclein in the rat substantia nigra using a novel AAV1\/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pathology of Parkinson\u2019s disease","volume":"5","author":"Koprich","year":"2010","unstructured":"PMID: 21029459","journal-title":"Mol. Neurodegener."},{"issue":"5","key":"10.59368\/agingbio.20230010_r205","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/NEN.0b013e3181a24b53","article-title":"Alpha-synuclein S129 phosphorylation mutants do not alter nigrostriatal toxicity in a rat model of Parkinson disease","volume":"68","author":"McFarland","year":"2009","unstructured":"PMID: 19525899","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"3","key":"10.59368\/agingbio.20230010_r206","doi-asserted-by":"publisher","first-page":"139","DOI":"10.14802\/jmd.19046","article-title":"Modeling \u03b1-synuclein propagation with preformed fibril injections","volume":"12","author":"Chung","year":"2019","unstructured":"PMID: 31556259","journal-title":"J. Mov. Disord."},{"issue":"4","key":"10.59368\/agingbio.20230010_r207","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3233\/JPD-212847","article-title":"A summary of phenotypes observed in the in vivo rodent alpha-synuclein preformed fibril model","volume":"11","author":"Polinski","year":"2021","unstructured":"PMID: 34486988","journal-title":"J. Parkinsons. Dis."},{"key":"10.59368\/agingbio.20230010_r208","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.nbd.2015.06.003","article-title":"Intrastriatal injection of pre-formed mouse \u03b1-synuclein fibrils into rats triggers \u03b1-synuclein pathology and bilateral nigrostriatal degeneration","volume":"82","author":"Paumier","year":"2015","unstructured":"PMID: 26093169","journal-title":"Neurobiol. Dis."},{"issue":"6109","key":"10.59368\/agingbio.20230010_r209","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","unstructured":"PMID: 23161999","journal-title":"Science."},{"issue":"29","key":"10.59368\/agingbio.20230010_r210","doi-asserted-by":"publisher","first-page":"10732","DOI":"10.1073\/pnas.1321785111","article-title":"Intramuscular injection of \u03b1-synuclein induces CNS \u03b1-synuclein pathology and a rapid-onset motor phenotype in transgenic mice","volume":"111","author":"Sacino","year":"2014","unstructured":"PMID: 25002524","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.59368\/agingbio.20230010_r211","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-019-0331-7","article-title":"Correction to: Inoculation of \u03b1-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve (Mol. Neurodegener. 10.1186\/s13024-018-0257-5)","volume":"14","author":"Uemura","year":"2019","unstructured":"PMID: 31349849","journal-title":"Mol. Neurodegener."},{"issue":"9","key":"10.59368\/agingbio.20230010_r212","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1084\/jem.20160368","article-title":"Widespread transneuronal propagation of \u03b1-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson\u2019s disease","volume":"213","author":"Rey","year":"2016","unstructured":"PMID: 27503075","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.59368\/agingbio.20230010_r213","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00401-017-1792-9","article-title":"Spread of aggregates after olfactory bulb injection of \u03b1-synuclein fibrils is associated with early neuronal loss and is reduced long term","volume":"135","author":"Rey","year":"2018","unstructured":"PMID: 29209768","journal-title":"Acta Neuropathol."},{"key":"10.59368\/agingbio.20230010_r214","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/B978-0-444-63945-5.00017-9","article-title":"Prion-like propagation of pathology in Parkinson disease","volume":"153","author":"Volpicelli-Daley","year":"2018","unstructured":"PMID: 29887143","journal-title":"Handb. Clin. Neurol."},{"issue":"8","key":"10.59368\/agingbio.20230010_r215","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.celrep.2015.01.060","article-title":"Progressive aggregation of alpha-synuclein and selective degeneration of lewy inclusion-bearing neurons in a mouse model of Parkinsonism","volume":"10","author":"Osterberg","year":"2015","unstructured":"PMID: 25732816","journal-title":"Cell Rep."},{"issue":"1","key":"10.59368\/agingbio.20230010_r216","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13041-020-00585-6","article-title":"Aging-related motor function and dopaminergic neuronal loss in C57BL\/6 mice","volume":"13","author":"Noda","year":"2020","unstructured":"PMID: 32293495","journal-title":"Mol. Brain"},{"issue":"4","key":"10.59368\/agingbio.20230010_r217","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","article-title":"Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease","volume":"103","author":"Kim","year":"2019","unstructured":"PMID: 31255487","journal-title":"Neuron"},{"issue":"3","key":"10.59368\/agingbio.20230010_r218","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","article-title":"Gut-seeded \u03b1-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice","volume":"23","author":"Challis","year":"2020","unstructured":"PMID: 32066981","journal-title":"Nat. Neurosci."},{"key":"10.59368\/agingbio.20230010_r219","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neurobiolaging.2021.01.010","article-title":"Age-related increase of alpha-synuclein oligomers is associated with motor disturbances in L61 transgenic mice","volume":"101","author":"Roshanbin","year":"2021","unstructured":"PMID: 33639338","journal-title":"Neurobiol. Aging"},{"issue":"2","key":"10.59368\/agingbio.20230010_r220","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/jnc.13409","article-title":"Chronic and progressive Parkinson\u2019s disease MPTP model in adult and aged mice","volume":"136","author":"Mu\u00f1oz-Manchado","year":"2016","unstructured":"PMID: 26500044","journal-title":"J. Neurochem."},{"issue":"1","key":"10.59368\/agingbio.20230010_r221","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.nbd.2006.11.013","article-title":"Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: Diminished compensatory mechanisms as a prelude to Parkinsonism","volume":"26","author":"Collier","year":"2007","unstructured":"PMID: 17254792","journal-title":"Neurobiol. Dis."},{"issue":"11","key":"10.59368\/agingbio.20230010_r222","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/glia.20690","article-title":"Age and region-specific responses of microglia, but not astrocytes, suggest a role in selective vulnerability of dopamine neurons after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure in monkeys","volume":"56","author":"Kanaan","year":"2008","unstructured":"PMID: 18484101","journal-title":"Glia"},{"issue":"16","key":"10.59368\/agingbio.20230010_r223","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1093\/hmg\/ddab118","article-title":"Nurr1 repression mediates cardinal features of Parkinson\u2019s disease in \u03b1-synuclein transgenic mice","volume":"30","author":"Argyrofthalmidou","year":"2021","unstructured":"PMID: 33902111","journal-title":"Hum. Mol. Genet."},{"issue":"9","key":"10.59368\/agingbio.20230010_r224","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.celrep.2016.04.071","article-title":"Inefficient DNA repair is an aging-related modifier of Parkinson\u2019s disease","volume":"15","author":"Sepe","year":"2016","unstructured":"PMID: 27210754","journal-title":"Cell Rep."},{"key":"10.59368\/agingbio.20230010_r225","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104717","article-title":"Loss of Parkin contributes to mitochondrial turnover and dopaminergic neuronal loss in aged mice","volume":"136","author":"Noda","year":"2020","unstructured":"PMID: 31846738","journal-title":"Neurobiol. Dis."},{"key":"10.59368\/agingbio.20230010_r226","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1016\/j.bbadis.2017.07.008","article-title":"Non-human primates as a model for aging","volume":"1864","author":"Colman","year":"2018","unstructured":"PMID: 28729086","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.59368\/agingbio.20230010_r227","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/978-3-642-67265-1_46","article-title":"Lifespan studies on male and female mice and rats under SPF-laboratory conditions","author":"Suter","year":"1979","unstructured":"PMID: 157120","journal-title":"Arch. Toxicol. Suppl."},{"key":"10.59368\/agingbio.20230010_r228","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mad.2016.10.001","article-title":"Mouse models of ageing and their relevance to disease","volume":"160","author":"K\u00f5ks","year":"2016","unstructured":"PMID: 27717883","journal-title":"Mech. Ageing Dev."},{"issue":"11","key":"10.59368\/agingbio.20230010_r229","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/nn.3537","article-title":"Maintaining genome stability in the nervous system","volume":"16","author":"McKinnon","year":"2013","unstructured":"PMID: 24165679","journal-title":"Nat. Neurosci."},{"issue":"7692","key":"10.59368\/agingbio.20230010_r230","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/d41586-018-01668-0","article-title":"Find drugs that delay many diseases of old age","volume":"554","author":"Bellantuono","year":"2018","unstructured":"PMID: 29446384","journal-title":"Nature"},{"issue":"6","key":"10.59368\/agingbio.20230010_r231","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/aje\/kwh059","article-title":"Obesity and the risk of Parkinson\u2019s disease","volume":"159","author":"Chen","year":"2004","unstructured":"PMID: 15003958","journal-title":"Am. J. Epidemiol."},{"key":"10.59368\/agingbio.20230010_r232","doi-asserted-by":"publisher","DOI":"10.1002\/trc2.12038","article-title":"Improving preclinical to clinical translation in Alzheimer\u2019s disease research","volume":"6","author":"Sukoff Rizzo","year":"2020","unstructured":"PMID: 32548237","journal-title":"Alzheimers Dement (N. Y.)"},{"key":"10.59368\/agingbio.20230010_r233","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1006\/neur.1995.0016","article-title":"6-Hydroxydopamine lesion of the rat substantia nigra: Time course and morphology of cell death.","volume":"4","author":"Jeon","year":"1995","unstructured":"PMID: 7583676","journal-title":"Neurodegener. J. Neurodegener. Disord. Neuroprotection, Neuroregeneration"},{"key":"10.59368\/agingbio.20230010_r234","doi-asserted-by":"publisher","DOI":"10.3791\/3234","article-title":"Development of a unilaterally-lesioned 6-OHDA mouse model of Parkinson\u2019s disease","author":"Thiele","year":"2012","unstructured":"PMID: 22370630","journal-title":"J. Vis. Exp."},{"issue":"4","key":"10.59368\/agingbio.20230010_r235","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","article-title":"In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining","volume":"77","author":"Tatton","year":"1997","unstructured":"PMID: 9130785","journal-title":"Neuroscience"},{"key":"10.59368\/agingbio.20230010_r236","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","article-title":"Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.","volume":"4","author":"Jackson-Lewis","year":"1995","unstructured":"PMID: 8581558","journal-title":"Neurodegener. J. Neurodegener. Disord. Neuroprotection, Neuroregeneration"},{"issue":"3","key":"10.59368\/agingbio.20230010_r237","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1602\/neurorx.2.3.484","article-title":"Toxin-induced models of Parkinson\u2019s disease","volume":"2","author":"Bov\u00e9","year":"2005","unstructured":"PMID: 16389312","journal-title":"NeuroRX"},{"issue":"3","key":"10.59368\/agingbio.20230010_r238","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.brainresbull.2005.08.005","article-title":"Marmoset monkey models of Parkinson\u2019s disease: Which model, when and why?","volume":"68","author":"Eslamboli","year":"2005","unstructured":"PMID: 16325013","journal-title":"Brain Res. Bull."},{"issue":"10","key":"10.59368\/agingbio.20230010_r239","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1002\/mds.22481","article-title":"No Lewy pathology in monkeys with over 10\u00a0years of severe MPTP Parkinsonism","volume":"24","author":"Halliday","year":"2009","unstructured":"PMID: 19526568","journal-title":"Mov. Disord."},{"issue":"1","key":"10.59368\/agingbio.20230010_r240","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.molbrainres.2005.01.012","article-title":"Absence of inclusion body formation in the MPTP mouse model of Parkinson\u2019s disease","volume":"134","author":"Shimoji","year":"2005","unstructured":"PMID: 15790534","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.59368\/agingbio.20230010_r241","first-page":"1000","article-title":"Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration","volume":"270","author":"Giovanni","year":"1994","unstructured":"PMID: 7932147","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1\u20132","key":"10.59368\/agingbio.20230010_r242","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0166-4328(01)00309-6","article-title":"Behavioral phenotyping of the MPTP mouse model of Parkinson\u2019s disease","volume":"125","author":"Sedelis","year":"2001","unstructured":"PMID: 11682102","journal-title":"Behav. Brain Res."},{"key":"10.59368\/agingbio.20230010_r243","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0079-6123(10)84007-5","article-title":"The MPTP-lesioned non-human primate models of Parkinson\u2019s disease. Past, present, and future","volume":"184","author":"Fox","year":"2010","unstructured":"PMID: 20887873","journal-title":"Prog. Brain Res."},{"issue":"4","key":"10.59368\/agingbio.20230010_r244","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2165\/00002018-199005040-00002","article-title":"Paraquat poisoning. An overview of the current status","volume":"5","author":"Bismuth","year":"1990","unstructured":"PMID: 2198050","journal-title":"Drug Saf."},{"key":"10.59368\/agingbio.20230010_r245","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1096\/fj.03-0677fje","article-title":"Rotenone induces non-specific central nervous system and systemic toxicity","volume":"18","author":"Lapointe","year":"2004","unstructured":"PMID: 14766796","journal-title":"FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol."},{"issue":"5","key":"10.59368\/agingbio.20230010_r246","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/jnr.10231","article-title":"Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters","volume":"68","author":"Rockenstein","year":"2002","unstructured":"PMID: 12111846","journal-title":"J. Neurosci. Res."},{"issue":"7","key":"10.59368\/agingbio.20230010_r247","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1002\/jnr.22611","article-title":"Elevated tonic extracellular dopamine concentration and altered dopamine modulation of synaptic activity precede dopamine loss in the striatum of mice overexpressing human \u03b1-synuclein","volume":"89","author":"Lam","year":"2011","unstructured":"PMID: 21488084","journal-title":"J. Neurosci. Res."},{"issue":"5\u20136","key":"10.59368\/agingbio.20230010_r248","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/00008877-200609000-00004","article-title":"Behavioral phenotypes and pharmacology in genetic mouse models of Parkinsonism","volume":"17","author":"Fleming","year":"2006","unstructured":"PMID: 16940759","journal-title":"Behav. Pharmacol."},{"issue":"42","key":"10.59368\/agingbio.20230010_r249","doi-asserted-by":"publisher","first-page":"9434","DOI":"10.1523\/JNEUROSCI.3080-04.2004","article-title":"Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein","volume":"24","author":"Fleming","year":"2004","unstructured":"PMID: 15496679","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"issue":"2","key":"10.59368\/agingbio.20230010_r250","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.expneurol.2012.06.025","article-title":"Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein","volume":"237","author":"Watson","year":"2012","unstructured":"PMID: 22750327","journal-title":"Exp. Neurol."},{"issue":"12","key":"10.59368\/agingbio.20230010_r251","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/syn.20456","article-title":"Behavioral and histopathological consequences of paraquat intoxication in mice: Effects of alpha-synuclein over-expression","volume":"61","author":"Fernagut","year":"2007","unstructured":"PMID: 17879265","journal-title":"Synapse"},{"key":"10.59368\/agingbio.20230010_r252","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.nbd.2013.10.005","article-title":"Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P \u03b1-synuclein BAC transgenic mouse","volume":"62","author":"Taylor","year":"2014","unstructured":"PMID: 24121116","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.59368\/agingbio.20230010_r253","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0896-6273(02)00682-7","article-title":"Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein","volume":"34","author":"Giasson","year":"2002","unstructured":"PMID: 12062037","journal-title":"Neuron"},{"issue":"9","key":"10.59368\/agingbio.20230010_r254","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.neurobiolaging.2006.06.013","article-title":"Age-dependent cognitive decline and amygdala pathology in alpha-synuclein transgenic mice","volume":"28","author":"Freichel","year":"2007","unstructured":"PMID: 16872721","journal-title":"Neurobiol. Aging"},{"key":"10.59368\/agingbio.20230010_r255","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134437","article-title":"Trichloroethylene and its metabolite TaClo lead to degeneration of substantia nigra dopaminergic neurones: Effects in wild type and human A30P mutant \u03b1-synuclein mice","volume":"711","author":"Keane","year":"2019","unstructured":"PMID: 31422098","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.59368\/agingbio.20230010_r256","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41531-018-0063-3","article-title":"Altered dopamine release and monoamine transporters in Vps35 p.D620N knock-in mice","volume":"4","author":"Cataldi","year":"2018","unstructured":"PMID: 30155515","journal-title":"NPJ Park. Dis."},{"key":"10.59368\/agingbio.20230010_r257","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.nbd.2014.06.009","article-title":"Phenotypic characterization of recessive gene knockout rat models of Parkinson\u2019s disease","volume":"70","author":"Dave","year":"2014","unstructured":"PMID: 24969022","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.59368\/agingbio.20230010_r258","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/mds.27296","article-title":"New developments in genetic rat models of Parkinson\u2019s disease","volume":"33","author":"Creed","year":"2018","unstructured":"PMID: 29418019","journal-title":"Mov. Disord."},{"issue":"11","key":"10.59368\/agingbio.20230010_r259","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1002\/jnr.23625","article-title":"Evidence for early and progressive ultrasonic vocalization and oromotor deficits in a PINK1 gene knockout rat model of Parkinson\u2019s disease","volume":"93","author":"Grant","year":"2015","unstructured":"PMID: 26234713","journal-title":"J. Neurosci. Res."},{"key":"10.59368\/agingbio.20230010_r260","doi-asserted-by":"publisher","first-page":"S185","DOI":"10.1016\/S1353-8020(09)70811-9","article-title":"The MitoPark mouse - An animal model of Parkinson\u2019s disease with impaired respiratory chain function in dopamine neurons.","volume":"15 Suppl 3","author":"Ekstrand","year":"2009","unstructured":"PMID: 20082987","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.59368\/agingbio.20230010_r261","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/978-3-319-49969-7_9","article-title":"Models of LRRK2-associated Parkinson\u2019s disease","volume":"14","author":"Xiong","year":"2017","unstructured":"PMID: 28353284","journal-title":"Adv. Neurobiol."},{"key":"10.59368\/agingbio.20230010_r262","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.67604","article-title":"Pharmacological rescue of impaired mitophagy in Parkinson\u2019s disease-related LRRK2 G2019S knock-in mice","volume":"10","author":"Singh","year":"2021","unstructured":"PMID: 34340748","journal-title":"Elife"},{"issue":"29","key":"10.59368\/agingbio.20230010_r263","doi-asserted-by":"publisher","first-page":"17296","DOI":"10.1073\/pnas.1922184117","article-title":"Dopaminergic neurodegeneration induced by Parkinson\u2019s disease-linked G2019S LRRK2 is dependent on kinase and GTPase activity.","volume":"117","author":"Nguyen","year":"2020","unstructured":"PMID: 32631998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.59368\/agingbio.20230010_r264","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1523\/JNEUROSCI.5092-10.2011","article-title":"A rat model of progressive nigral neurodegeneration induced by the Parkinson\u2019s disease-associated G2019S mutation in LRRK2","volume":"31","author":"Dusonchet","year":"2011","unstructured":"PMID: 21248115","journal-title":"J. Neurosci. Off. J. Soc. Neurosci."},{"key":"10.59368\/agingbio.20230010_r265","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/7854_2014_310","article-title":"Viral vector-based models of Parkinson\u2019s disease","volume":"22","author":"Van der Perren","year":"2015","unstructured":"PMID: 24839101","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.59368\/agingbio.20230010_r266","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/jnc.13627","article-title":"How can rAAV-\u03b1-synuclein and the fibril \u03b1-synuclein models advance our understanding of Parkinson\u2019s disease?","volume":"139 Suppl","author":"Volpicelli-Daley","year":"2016","unstructured":"PMID: 27018978","journal-title":"J. Neurochem."},{"issue":"6109","key":"10.59368\/agingbio.20230010_r267","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","unstructured":"PMID: 23161999","journal-title":"Science"},{"issue":"1","key":"10.59368\/agingbio.20230010_r268","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous \u03b1-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Volpicelli-Daley","year":"2011","unstructured":"PMID: 21982369","journal-title":"Neuron"},{"issue":"1","key":"10.59368\/agingbio.20230010_r269","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-018-1171-z","article-title":"Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degeneration","volume":"15","author":"Duffy","year":"2018","unstructured":"PMID: 29716614","journal-title":"J. Neuroinflammation"},{"key":"10.59368\/agingbio.20230010_r270","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.nbd.2018.01.008","article-title":"Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology","volume":"112","author":"Manfredsson","year":"2018","unstructured":"PMID: 29341898","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.59368\/agingbio.20230010_r271","doi-asserted-by":"publisher","first-page":"785","DOI":"10.14336\/AD.2017.1028","article-title":"The synergy of aging and LPS exposure in a mouse model of Parkinson\u2019s disease","volume":"9","author":"Zhao","year":"2018","unstructured":"PMID: 30271656","journal-title":"Aging Dis."},{"issue":"26","key":"10.59368\/agingbio.20230010_r272","doi-asserted-by":"publisher","first-page":"6914","DOI":"10.1523\/JNEUROSCI.1569-07.2007","article-title":"Iron and paraquat as synergistic environmental risk factors in sporadic Parkinson\u2019s disease accelerate age-related neurodegeneration","volume":"27","author":"Peng","year":"2007","unstructured":"PMID: 17596439","journal-title":"J. Neurosci."},{"issue":"1","key":"10.59368\/agingbio.20230010_r273","doi-asserted-by":"publisher","DOI":"10.1038\/srep40887","article-title":"Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson\u2019s disease","volume":"7","author":"Liu","year":"2017","unstructured":"PMID: 28098219","journal-title":"Sci. Rep."},{"issue":"10","key":"10.59368\/agingbio.20230010_r274","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21103459","article-title":"Impact of aging on the 6-OHDA-induced rat model of Parkinson\u2019s disease","volume":"21","author":"Barata-Antunes","year":"2020","unstructured":"PMID: 32422916","journal-title":"Int. J. Mol. Sci."},{"key":"10.59368\/agingbio.20230010_r275","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S81539","article-title":"Aging-related rotenone-induced neurochemical and behavioral deficits: role of SIRT2 and redox imbalance, and neuroprotection by AK-7.","volume":"2553","author":"Wang","year":"2015","unstructured":"PMID: 26089639","journal-title":"Drug Des. Devel. Ther."},{"issue":"3","key":"10.59368\/agingbio.20230010_r276","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1177\/0192623318767065","article-title":"Effects of aging in the striatum and substantia nigra of a Parkinson\u2019s disease animal model","volume":"46","author":"Ureshino","year":"2018","unstructured":"PMID: 29683090","journal-title":"Toxicol. Pathol."},{"issue":"48","key":"10.59368\/agingbio.20230010_r277","doi-asserted-by":"publisher","first-page":"17649","DOI":"10.1523\/JNEUROSCI.4871-11.2011","article-title":"Striatal dysfunctions associated with mitochondrial DNA damage in dopaminergic neurons in a mouse model of Parkinson\u2019s disease","volume":"31","author":"Pickrell","year":"2011","unstructured":"PMID: 22131425","journal-title":"J. Neurosci."},{"issue":"7","key":"10.59368\/agingbio.20230010_r278","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1523\/JNEUROSCI.5351-08.2009","article-title":"Bacterial artificial chromosome transgenic mice expressing a truncated mutant Parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein","volume":"29","author":"Lu","year":"2009","unstructured":"PMID: 19228951","journal-title":"J. Neurosci."},{"issue":"11","key":"10.59368\/agingbio.20230010_r279","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1007\/s00702-018-1887-z","article-title":"An inducible MAO-B mouse model of Parkinson\u2019s disease: a tool towards better understanding basic disease mechanisms and developing novel therapeutics","volume":"125","author":"Chamoli","year":"2018","unstructured":"PMID: 29713806","journal-title":"J. Neural Transm."},{"issue":"1","key":"10.59368\/agingbio.20230010_r280","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0054200","article-title":"Age-related behavioral phenotype of an astrocytic monoamine oxidase-b transgenic mouse model of Parkinson\u2019s disease","volume":"8","author":"Lieu","year":"2013","unstructured":"PMID: 23326597","journal-title":"PLoS One"},{"issue":"4","key":"10.59368\/agingbio.20230010_r281","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060378","article-title":"Age-dependent effects of A53T alpha-synuclein on behavior and dopaminergic function","volume":"8","author":"Oaks","year":"2013","unstructured":"PMID: 23560093","journal-title":"PLoS One"},{"issue":"8","key":"10.59368\/agingbio.20230010_r282","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0070274","article-title":"Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson\u2019s disease","volume":"8","author":"Paumier","year":"2013","unstructured":"PMID: 23936403","journal-title":"PLoS One"},{"issue":"51","key":"10.59368\/agingbio.20230010_r283","doi-asserted-by":"publisher","first-page":"13997","DOI":"10.1523\/JNEUROSCI.3885-07.2007","article-title":"Inducible alterations of glutathione levels in adult dopaminergic midbrain neurons result in nigrostriatal degeneration","volume":"27","author":"Chinta","year":"2007","unstructured":"PMID: 18094238","journal-title":"J. Neurosci."},{"issue":"5","key":"10.59368\/agingbio.20230010_r284","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/acel.13347","article-title":"VPS35 D620N knockin mice recapitulate cardinal features of Parkinson\u2019s disease","volume":"20","author":"Niu","year":"2021","unstructured":"PMID: 33745227","journal-title":"Aging Cell"},{"issue":"4","key":"10.59368\/agingbio.20230010_r285","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.neuron.2005.01.041","article-title":"Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial parkinsonism-linked gene DJ-1","volume":"45","author":"Goldberg","year":"2005","unstructured":"PMID: 15721235","journal-title":"Neuron"},{"issue":"14","key":"10.59368\/agingbio.20230010_r286","doi-asserted-by":"publisher","first-page":"4026","DOI":"10.1523\/JNEUROSCI.1395-15.2016","article-title":"Dopaminergic neurons exhibit an age-dependent decline in electrophysiological parameters in the MitoPark mouse model of Parkinson\u2019s disease","volume":"36","author":"Branch","year":"2016","unstructured":"PMID: 27053209","journal-title":"J. Neurosci."},{"issue":"6","key":"10.59368\/agingbio.20230010_r287","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0005777","article-title":"Parkinson phenotype in aged PINK1-deficient mice is accompanied by progressive mitochondrial dysfunction in absence of neurodegeneration","volume":"4","author":"Gispert","year":"2009","unstructured":"PMID: 19492057","journal-title":"PLoS One"},{"issue":"6","key":"10.59368\/agingbio.20230010_r288","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1093\/brain\/awab061","article-title":"Ageing promotes pathological alpha-synuclein propagation and autonomic dysfunction in wild-type rats.","volume":"144","author":"Van Den Berge","year":"2021","unstructured":"PMID: 33880502","journal-title":"Brain"},{"issue":"1","key":"10.59368\/agingbio.20230010_r289","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08858-y","article-title":"Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson\u2019s disease pathogenesis","volume":"10","author":"Carballo-Carbajal","year":"2019","unstructured":"PMID: 30846695","journal-title":"Nat. Commun."},{"issue":"21","key":"10.59368\/agingbio.20230010_r290","doi-asserted-by":"publisher","first-page":"8345","DOI":"10.1523\/JNEUROSCI.0772-15.2015","article-title":"Mutant alpha-synuclein causes age-dependent neuropathology in monkey brain","volume":"35","author":"Yang","year":"2015","unstructured":"PMID: 26019347","journal-title":"J. Neurosci."}],"container-title":["Aging Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/agingcelljournal.org\/Archive\/Volume3\/ageing_parkinsons_disease_and_models\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T15:48:50Z","timestamp":1691164130000},"score":1,"resource":{"primary":{"URL":"https:\/\/agingcelljournal.org\/Archive\/Volume3\/ageing_parkinsons_disease_and_models\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,4]]},"references-count":290,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,8,4]]}},"URL":"https:\/\/doi.org\/10.59368\/agingbio.20230010","relation":{},"subject":[],"published":{"date-parts":[[2023,8,4]]}}}